会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 51. 发明授权
    • Rotor with slot wedges having different dimension to reduce stress
    • 转子具有不同尺寸的槽楔,以减轻应力
    • US06774522B2
    • 2004-08-10
    • US10263696
    • 2002-10-04
    • Hiroshi AoyamaHidehiro EjimaKazuo Gotou
    • Hiroshi AoyamaHidehiro EjimaKazuo Gotou
    • H02K3487
    • H02K3/487H02K19/22
    • A rotor structure is to be provided which can diminish stress concentration in teeth-wedge fitting portions located near magnetic poles of a rotor in a rotary electric machine. Teeth 6 have slant faces for abutment against slant faces of wedges 8 to retain the wedges in a fitted state between adjacent teeth, the wedges 8 having slant faces each formed at a predetermined angle relative to the radial direction of a rotor 1, and a circular arc is formed at each slant face rising position in the teeth 6. In this case, the radius of the circular arc formed at each slant face rising position 12 in a preset number of teeth 6 located near magnetic pole portions 7 of the rotor 1 is set larger that of the circular arc formed in the remaining teeth.
    • 提供一种转子结构,其可以减少旋转电机中位于转子的磁极附近的齿 - 楔配合部分中的应力集中。 齿6具有用于抵靠楔形物8的倾斜面的倾斜面,以将楔形件保持在相邻齿之间的装配状态,楔形件8具有相对于转子1的径向以预定角度形成的倾斜面,圆形 在齿6中的每个倾斜面上升位置处形成弧。在这种情况下,在位于转子1的磁极部7附近的预定数量的齿6中的每个倾斜面上升位置12处形成的圆弧的半径为 设定为大于在剩余牙齿中形成的圆弧的距离。
    • 60. 发明申请
    • ANTI-VIRAL AGENT CONTAINING HETEROCYCLIC AROMATIC COMPOUND AS ACTIVE INGREDIENT
    • 含有作为活性成分的杂环芳族化合物的抗病毒剂
    • US20100256379A1
    • 2010-10-07
    • US12739795
    • 2008-10-22
    • Masanori BabaYuichi HashimotoHiroshi AoyamaKumiko SakoShinichi SatoKatsuyuki Nagai
    • Masanori BabaYuichi HashimotoHiroshi AoyamaKumiko SakoShinichi SatoKatsuyuki Nagai
    • C07D471/04
    • C07D209/86C07D307/91C07D471/04
    • The present invention relates to an anti-viral agent comprising a compound represented by the following formula (I): (wherein X represents CH, a nitrogen atom, an oxygen atom, or a sulfur atom; Y and Z are the same or different and each represents a nitrogen atom or C—R8, and at least one of them represents a nitrogen atom; R1 to R8 are the same or different and each represents a hydrogen atom, a linear C1-10-hydrocarbon group, a hydroxy group, or a substituted or unsubstituted benzyl group; and, when X represents an oxygen atom or a sulfur atom, R5 is absent), or the following formula (II): (wherein X′ represents CH or a nitrogen atom; Y′ and Z′ are the same or different and each represents a nitrogen atom or N—R9, or C—R8 and at least one of them represents a nitrogen atom or N—R9; R1 to R4 and R6 to R8 are as defined above; R9 represents a hydrogen atom, a linear C1-10-hydrocarbon group, a hydroxy group, or a substituted or unsubstituted benzyl group; and, the C ring has the maximum number of double bonds at the dotted line portion) or a pharmaceutically acceptable salt thereof.
    • 本发明涉及包含由下式(I)表示的化合物的抗病毒剂:(其中X表示CH,氮原子,氧原子或硫原子; Y和Z相同或不同, 各自表示氮原子或C-R8,并且其中至少一个表示氮原子; R 1〜R 8相同或不同,表示氢原子,直链C 1-10烃基,羟基或 取代或未取代的苄基;当X表示氧原子或硫原子时,R 5不存在)或下式(II)表示:(其中X'表示CH或氮原子,Y'和Z'为 相同或不同,各自表示氮原子或N-R9或C-R8,并且其中至少一个表示氮原子或N-R 9; R 1至R 4和R 6至R 8如上所定义; R 9表示氢 原子,直链C 1-10烃基,羟基或取代或未取代的苄基;和C环h 作为虚线部分的双键的最大数目)或其药学上可接受的盐。